{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:42:48Z","timestamp":1791909768192,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["RS-2021-NR065780"],"award-info":[{"award-number":["RS-2021-NR065780"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00109-025-02569-2","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T09:32:57Z","timestamp":1751707977000},"page":"1043-1053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sex hormone-binding globulin restrains hepatic fibrosis via inhibition of Tgf\u03b2 expression"],"prefix":"10.1007","volume":"103","author":[{"given":"Sang R.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeka","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9640-8841","authenticated-orcid":false,"given":"Eui-Ju","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"2569_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1159\/000444556","volume":"34","author":"R Weiskirchen","year":"2016","unstructured":"Weiskirchen R, Tacke F (2016) Liver fibrosis: from pathogenesis to novel therapies. Dig Dis 34:410\u2013422","journal-title":"Dig Dis"},{"key":"2569_CR2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gines","year":"2021","unstructured":"Gines P, Krag A, Abraldes JG, Sola E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet 398:1359\u20131376","journal-title":"Lancet"},{"key":"2569_CR3","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/hep.25915","volume":"56","author":"EA Tsochatzis","year":"2012","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK (2012) New therapeutic paradigm for patients with cirrhosis. Hepatology 56:1983\u20131992","journal-title":"Hepatology"},{"key":"2569_CR4","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41591-021-01495-3","volume":"27","author":"V Ratziu","year":"2021","unstructured":"Ratziu V, de Guevara L, Safadi R, Poordad F, Fuster F, Flores-Figueroa J, Arrese M, Fracanzani AL, Ben Bashat D, Lackner K et al (2021) Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nat Med 27:1825\u20131835","journal-title":"Nat Med"},{"key":"2569_CR5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/hep.31108","volume":"72","author":"V Ratziu","year":"2020","unstructured":"Ratziu V, Sanyal A, Harrison SA, Wong VW, Francque S, Goodman Z, Aithal GP, Kowdley KV, Seyedkazemi S, Fischer L et al (2020) Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study. Hepatology 72:892\u2013905","journal-title":"Hepatology"},{"key":"2569_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/j.gastro.2018.07.006","volume":"155","author":"SA Harrison","year":"2018","unstructured":"Harrison SA, Abdelmalek MF, Caldwell S, Shiffman ML, Diehl AM, Ghalib R, Lawitz EJ, Rockey DC, Schall RA, Jia C et al (2018) Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis. Gastroenterology 155:1140\u20131153","journal-title":"Gastroenterology"},{"key":"2569_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14728214.2021.1918099","volume":"26","author":"JA Fallowfield","year":"2021","unstructured":"Fallowfield JA, Jimenez-Ramos M, Robertson A (2021) Emerging synthetic drugs for the treatment of liver cirrhosis. Expert Opin Emerg Drugs 26:149\u2013163","journal-title":"Expert Opin Emerg Drugs"},{"key":"2569_CR8","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/JOE-16-0070","volume":"230","author":"GL Hammond","year":"2016","unstructured":"Hammond GL (2016) Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J Endocrinol 230:R13-25","journal-title":"J Endocrinol"},{"key":"2569_CR9","doi-asserted-by":"publisher","first-page":"35539","DOI":"10.1038\/srep35539","volume":"6","author":"MR Laurent","year":"2016","unstructured":"Laurent MR, Hammond GL, Blokland M, Jardi F, Antonio L, Dubois V, Khalil R, Sterk SS, Gielen E, Decallonne B et al (2016) Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis. Sci Rep 6:35539","journal-title":"Sci Rep"},{"key":"2569_CR10","doi-asserted-by":"publisher","first-page":"C1685","DOI":"10.1152\/ajpcell.00747.2024","volume":"328","author":"SR Lee","year":"2025","unstructured":"Lee SR, Kim NR, Mukae M, Won YS, Hong EJ (2025) Sex hormone-binding globulin dampens growth and metastasis of breast cancer in an estrogen-independent manner. Am J Physiol Cell Physiol 328:C1685\u2013C1698","journal-title":"Am J Physiol Cell Physiol"},{"key":"2569_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/carcin\/bgz107","volume":"40","author":"SR Lee","year":"2019","unstructured":"Lee SR, Lee YH, Yang H, Lee HW, Lee GS, An BS, Jeung EB, Park BK, Hong EJ (2019) Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause. Carcinogenesis 40:1031\u20131041","journal-title":"Carcinogenesis"},{"key":"2569_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108480","volume":"85","author":"C Saez-Lopez","year":"2020","unstructured":"Saez-Lopez C, Villena JA, Simo R, Selva DM (2020) Sex hormone-binding globulin overexpression protects against high-fat diet-induced obesity in transgenic male mice. J Nutr Biochem 85:108480","journal-title":"J Nutr Biochem"},{"key":"2569_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1210\/jc.2018-00740","volume":"104","author":"C Saez-Lopez","year":"2019","unstructured":"Saez-Lopez C, Salcedo-Allende MT, Hernandez C, Simo-Servat O, Simo R, Selva DM (2019) Sex hormone-binding globulin expression correlates with acetyl-coenzyme A carboxylase and triglyceride content in human liver. J Clin Endocrinol Metab 104:1500\u20131507","journal-title":"J Clin Endocrinol Metab"},{"key":"2569_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.10.003","author":"SR Lee","year":"2021","unstructured":"Lee SR, Hong E-J (2021) Sex hormone-binding globulin impedes hepatocellular carcinoma growth via MERTK regulation. Genes & Diseases. https:\/\/doi.org\/10.1016\/j.gendis.2021.10.003","journal-title":"Genes & Diseases"},{"key":"2569_CR15","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1182\/blood-2013-09-528752","volume":"123","author":"JH van der Meer","year":"2014","unstructured":"van der Meer JH, van der Poll T, van\u2019t Veer C (2014) TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis. Blood 123:2460\u20132469","journal-title":"Blood"},{"key":"2569_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12026-022-09267-y","volume":"70","author":"N Shi","year":"2022","unstructured":"Shi N, Wang Z, Zhu H, Liu W, Zhao M, Jiang X, Zhao J, Ren C, Zhang Y, Luo L (2022) Research progress on drugs targeting the TGF-beta signaling pathway in fibrotic diseases. Immunol Res 70:276\u2013288","journal-title":"Immunol Res"},{"key":"2569_CR17","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1111\/bph.13945","volume":"174","author":"T Luangmonkong","year":"2017","unstructured":"Luangmonkong T, Suriguga S, Bigaeva E, Boersema M, Oosterhuis D, de Jong KP, Schuppan D, Mutsaers HAM, Olinga P (2017) Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. Br J Pharmacol 174:3107\u20133117","journal-title":"Br J Pharmacol"},{"key":"2569_CR18","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1021\/acs.molpharmaceut.0c00633","volume":"17","author":"J Zhang","year":"2020","unstructured":"Zhang J, Li R, Liu Q, Zhou J, Huang H, Huang Y, Zhang Z, Wu T, Tang Q, Huang C et al (2020) SB431542-loaded liposomes alleviate liver fibrosis by suppressing TGF-beta signaling. Mol Pharm 17:4152\u20134162","journal-title":"Mol Pharm"},{"key":"2569_CR19","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1111\/bph.14831","volume":"176","author":"J Liu","year":"2019","unstructured":"Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C, Liu X, Zhang R, Wang Y (2019) Praziquantel ameliorates CCl4 -induced liver fibrosis in mice by inhibiting TGF-beta\/Smad signalling via up-regulating Smad7 in hepatic stellate cells. Br J Pharmacol 176:4666\u20134680","journal-title":"Br J Pharmacol"},{"key":"2569_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ebiom.2019.01.009","volume":"40","author":"J Li","year":"2019","unstructured":"Li J, Wang Y, Ma M, Jiang S, Zhang X, Zhang Y, Yang X, Xu C, Tian G, Li Q et al (2019) Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-beta signaling. EBioMedicine 40:43\u201355","journal-title":"EBioMedicine"},{"key":"2569_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jcmgh.2021.05.017","volume":"12","author":"YC Hsieh","year":"2021","unstructured":"Hsieh YC, Lee KC, Lei HJ, Lan KH, Huo TI, Lin YT, Chan CC, Schnabl B, Huang YH, Hou MC et al (2021) (Pro)renin receptor knockdown attenuates liver fibrosis through inactivation of ERK\/TGF-beta1\/SMAD3 pathway. Cell Mol Gastroenterol Hepatol 12:813\u2013838","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2569_CR22","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.27492","volume":"61","author":"P Reichl","year":"2015","unstructured":"Reichl P, Dengler M, van Zijl F, Huber H, Fuhrlinger G, Reichel C, Sieghart W, Peck-Radosavljevic M, Grubinger M, Mikulits W (2015) Axl activates autocrine transforming growth factor-beta signaling in hepatocellular carcinoma. Hepatology 61:930\u2013941","journal-title":"Hepatology"},{"key":"2569_CR23","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14091","volume":"7","author":"L Landolt","year":"2019","unstructured":"Landolt L, Furriol J, Babickova J, Ahmed L, Eikrem O, Skogstrand T, Scherer A, Suliman S, Leh S, Lorens JB et al (2019) AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction. Physiol Rep 7:e14091","journal-title":"Physiol Rep"},{"key":"2569_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jcmgh.2019.10.010","volume":"9","author":"A Tutusaus","year":"2020","unstructured":"Tutusaus A, de Gregorio E, Cucarull B, Cristobal H, Areste C, Graupera I, Coll M, Colell A, Gausdal G, Lorens JB et al (2020) A functional role of GAS6\/TAM in nonalcoholic steatohepatitis progression implicates AXL as therapeutic target. Cell Mol Gastroenterol Hepatol 9:349\u2013368","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2569_CR25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2015.04.013","volume":"63","author":"C Barcena","year":"2015","unstructured":"Barcena C, Stefanovic M, Tutusaus A, Joannas L, Menendez A, Garcia-Ruiz C, Sancho-Bru P, Mari M, Caballeria J, Rothlin CV et al (2015) Gas6\/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. J Hepatol 63:670\u2013678","journal-title":"J Hepatol"},{"key":"2569_CR26","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1210\/endo.140.9.7004","volume":"140","author":"M Janne","year":"1999","unstructured":"Janne M, Hogeveen KN, Deol HK, Hammond GL (1999) Expression and regulation of human sex hormone-binding globulin transgenes in mice during development. Endocrinology 140:4166\u20134174","journal-title":"Endocrinology"},{"key":"2569_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1210\/mend.12.1.0050","volume":"12","author":"M Janne","year":"1998","unstructured":"Janne M, Deol HK, Power SG, Yee SP, Hammond GL (1998) Human sex hormone-binding globulin gene expression in transgenic mice. Mol Endocrinol 12:123\u2013136","journal-title":"Mol Endocrinol"},{"key":"2569_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcmgh.2018.09.005","volume":"7","author":"R Martin-Mateos","year":"2019","unstructured":"Martin-Mateos R, De Assuncao TM, Arab JP, Jalan-Sakrikar N, Yaqoob U, Greuter T, Verma VK, Mathison AJ, Cao S, Lomberk G et al (2019) Enhancer of zeste homologue 2 inhibition attenuates TGF-beta dependent hepatic stellate cell activation and liver fibrosis. Cell Mol Gastroenterol Hepatol 7:197\u2013209","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2569_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-3701-2-9","volume":"2","author":"F Huang","year":"2012","unstructured":"Huang F, Chen YG (2012) Regulation of TGF-beta receptor activity. Cell Biosci 2:9","journal-title":"Cell Biosci"},{"key":"2569_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","volume":"3","author":"S Colak","year":"2017","unstructured":"Colak S, Ten Dijke P (2017) Targeting TGF-beta signaling in cancer. Trends in cancer 3:56\u201371","journal-title":"Trends in cancer"},{"key":"2569_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.gendis.2019.12.008","volume":"7","author":"YL Lin","year":"2020","unstructured":"Lin YL, Li Y (2020) Study on the hepatocellular carcinoma model with metastasis. Genes Dis 7:336\u2013350","journal-title":"Genes Dis"},{"key":"2569_CR32","first-page":"1382","volume":"31","author":"Y Lu","year":"2017","unstructured":"Lu Y, Wan J, Yang Z, Lei X, Niu Q, Jiang L, Passtoors WM, Zang A, Fraering PC, Wu F (2017) Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells. FASEB J Off Public Feder Am Soc Exp Biol 31:1382\u20131397","journal-title":"FASEB J Off Public Feder Am Soc Exp Biol"},{"key":"2569_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-019-0377-8","volume":"17","author":"M Lauter","year":"2019","unstructured":"Lauter M, Weber A, Torka R (2019) Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation. Cell Commun Signal 17:59","journal-title":"Cell Commun Signal"},{"key":"2569_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/JCI93557","volume":"128","author":"J Herrera","year":"2018","unstructured":"Herrera J, Henke CA, Bitterman PB (2018) Extracellular matrix as a driver of progressive fibrosis. J Clin Investig 128:45\u201353","journal-title":"J Clin Investig"},{"key":"2569_CR35","doi-asserted-by":"publisher","unstructured":"Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harbor perspectives in biology 3. https:\/\/doi.org\/10.1101\/cshperspect.a005058","DOI":"10.1101\/cshperspect.a005058"},{"key":"2569_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fonc.2018.00145","volume":"8","author":"V Gkretsi","year":"2018","unstructured":"Gkretsi V, Stylianopoulos T (2018) Cell adhesion and matrix stiffness: coordinating cancer cell invasion and metastasis. Front Oncol 8:145","journal-title":"Front Oncol"},{"key":"2569_CR37","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI39675","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R (2009) EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Investig 119:1417\u20131419","journal-title":"J Clin Investig"},{"key":"2569_CR38","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/hep.23196","volume":"50","author":"SS Choi","year":"2009","unstructured":"Choi SS, Diehl AM (2009) Epithelial-to-mesenchymal transitions in the liver. Hepatology 50:2007\u20132013","journal-title":"Hepatology"},{"key":"2569_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2337\/db11-0727","volume":"61","author":"R Simo","year":"2012","unstructured":"Simo R, Barbosa-Desongles A, Lecube A, Hernandez C, Selva DM (2012) Potential role of tumor necrosis factor-alpha in downregulating sex hormone-binding globulin. Diabetes 61:372\u2013382","journal-title":"Diabetes"},{"key":"2569_CR40","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1210\/me.2012-1152","volume":"26","author":"R Simo","year":"2012","unstructured":"Simo R, Barbosa-Desongles A, Hernandez C, Selva DM (2012) IL1beta down-regulation of sex hormone-binding globulin production by decreasing HNF-4alpha via MEK-1\/2 and JNK MAPK pathways. Mol Endocrinol 26:1917\u20131927","journal-title":"Mol Endocrinol"},{"key":"2569_CR41","doi-asserted-by":"publisher","unstructured":"Brianso-Llort L, Fuertes-Rioja L, Ramos-Perez L, Salcedo-Allende MT, Hernandez C, Simo R, Selva DM (2022) Transforming growth factor-beta 1: a new factor reducing hepatic SHBG production in liver fibrosis. J Cell Physiol. https:\/\/doi.org\/10.1002\/jcp.30818","DOI":"10.1002\/jcp.30818"},{"key":"2569_CR42","doi-asserted-by":"publisher","first-page":"3062319","DOI":"10.1155\/2018\/3062319","volume":"2018","author":"H Yamazaki","year":"2018","unstructured":"Yamazaki H, Kushiyama A, Sakoda H, Fujishiro M, Yamamotoya T, Nakatsu Y, Kikuchi T, Kaneko S, Tanaka H, Asano T (2018) Protective effect of sex hormone-binding globulin against metabolic syndrome: in vitro evidence showing anti-inflammatory and lipolytic effects on adipocytes and macrophages. Mediators Inflamm 2018:3062319","journal-title":"Mediators Inflamm"},{"key":"2569_CR43","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/carcin\/bgt372","volume":"35","author":"HJ Lee","year":"2014","unstructured":"Lee HJ, Jeng YM, Chen YL, Chung L, Yuan RH (2014) Gas6\/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma. Carcinogenesis 35:769\u2013775","journal-title":"Carcinogenesis"},{"key":"2569_CR44","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41416-018-0373-6","volume":"120","author":"DJ Pinato","year":"2019","unstructured":"Pinato DJ, Brown MW, Trousil S, Aboagye EO, Beaumont J, Zhang H, Coley HM, Mauri FA, Sharma R (2019) Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma. Br J Cancer 120:512\u2013521","journal-title":"Br J Cancer"},{"key":"2569_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.554","volume":"8","author":"K Staufer","year":"2017","unstructured":"Staufer K, Dengler M, Huber H, Marculescu R, Stauber R, Lackner C, Dienes HP, Kivaranovic D, Schachner C, Zeitlinger M et al (2017) The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis. Cell Death Dis 8:e3135","journal-title":"Cell Death Dis"},{"key":"2569_CR46","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1074\/jbc.RA119.012186","volume":"295","author":"X Song","year":"2020","unstructured":"Song X, Akasaka H, Wang H, Abbasgholizadeh R, Shin JH, Zang F, Chen J, Logsdon CD, Maitra A, Bean AJ et al (2020) Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer. J Biol Chem 295:2348\u20132358","journal-title":"J Biol Chem"},{"key":"2569_CR47","doi-asserted-by":"publisher","first-page":"E817","DOI":"10.1152\/ajpendo.00427.2019","volume":"318","author":"X Ma","year":"2020","unstructured":"Ma X, Zhou Y, Qiao B, Jiang S, Shen Q, Han Y, Liu A, Chen X, Wei L, Zhou L et al (2020) Androgen aggravates liver fibrosis by activation of NLRP3 inflammasome in CCl4-induced liver injury mouse model. Am J Physiol Endocrinol Metab 318:E817\u2013E829","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2569_CR48","doi-asserted-by":"publisher","unstructured":"Khanam A, Saleeb PG, Kottilil S (2021) Pathophysiology and treatment options for hepatic fibrosis: can it be completely cured?. Cells 10. https:\/\/doi.org\/10.3390\/cells10051097","DOI":"10.3390\/cells10051097"},{"key":"2569_CR49","doi-asserted-by":"publisher","first-page":"15853","DOI":"10.1074\/jbc.M512370200","volume":"281","author":"KM Ng","year":"2006","unstructured":"Ng KM, Catalano MG, Pinos T, Selva DM, Avvakumov GV, Munell F, Hammond GL (2006) Evidence that fibulin family members contribute to the steroid-dependent extravascular sequestration of sex hormone-binding globulin. J Biol Chem 281:15853\u201315861","journal-title":"J Biol Chem"},{"key":"2569_CR50","doi-asserted-by":"publisher","unstructured":"Liu G, Cooley MA, Jarnicki AG, Borghuis T, Nair PM, Tjin G, Hsu AC, Haw TJ, Fricker M, Harrison CL, et al. (2019) Fibulin-1c regulates transforming growth factor-beta activation in pulmonary tissue fibrosis. JCI insight 5. https:\/\/doi.org\/10.1172\/jci.insight.124529","DOI":"10.1172\/jci.insight.124529"},{"key":"2569_CR51","doi-asserted-by":"publisher","unstructured":"Bakrania A, Mo Y, Zheng G, Bhat M (2023) RNA nanomedicine in liver diseases. Hepatology. https:\/\/doi.org\/10.1097\/HEP.0000000000000606","DOI":"10.1097\/HEP.0000000000000606"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02569-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02569-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02569-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:07:51Z","timestamp":1756998471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02569-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2569"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02569-2","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mice experiments were approved and performed in accordance with the Chungnam National University Animal Care Committee (CNU-00917).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}